Investors can expect a company’s stock to rise or fall based on the buying and selling of stock by its insiders. Nektar Therapeutics shares valued at $10,403 were sold by Zalevsky Jonathan on Feb 19 ’25. At $1.01 per share, Zalevsky Jonathan sold 10,300 shares. The insider’s holdings dropped to 316,604 shares worth approximately $0.28 million following the completion of this transaction.
Also, Wilson Mark Andrew sold 11,040 shares, netting a total of over 11,150 in proceeds. Following the sale of shares at $1.01 each, the insider now holds 324,292 shares.
Before that, ROBIN HOWARD W had sold 23,774 shares from its account. In a trade valued at $24,012, the President & CEO traded Nektar Therapeutics shares for $1.01 each. Upon closing the transaction, the insider’s holdings decreased to 23,774 shares, worth approximately $0.95 million.
As published in a research note from Oppenheimer on March 14, 2025, Nektar Therapeutics [NKTR] has been rated up from a Perform to an Outperform and the price target has been revised to $6. Analysts at B. Riley Securities started covering the stock with ‘”a Buy”‘ outlook in a report released in early January. As of December 10, 2024, H.C. Wainwright has initiated its “Buy” rating for NKTR. Earlier on November 04, 2024, Piper Sandler initiated its rating. Their recommendation was “an Overweight” for NKTR stock.
Analyzing NKTR Stock Performance
During the last five days, there has been a surge of approximately 7.10%. Over the course of the year, Nektar Therapeutics shares have dropped approximately -6.10%. Shares of the company reached a 52-week high of $1.2500 on 01/07/25 and a 52-week low of $0.6500 on 02/12/25. A 50-day SMA is recorded $0.8698, while a 200-day SMA reached $1.1331.
Support And Resistance Levels for Nektar Therapeutics (NKTR)
According to the 24-hour chart, there is a support level at 0.8383, which, if violated, would cause prices to drop to 0.8033. In the upper region, resistance lies at 0.9242. The next price resistance is at 0.9751. RSI (Relative Strength Index) is 51.17 on the 14-day chart, showing neutral technical sentiment. Moving Average Convergence Divergence (MACD) is at 0.0284, which suggests the price will decrease in the coming days. Percent R is at 46.73%, indicating low price movement. Stochastics %K at holding indicates that the stock is to be held.
